Shares of REGN Up 25.2% Since Uptrend Call on Shares
Tuesday, July 18, 2017
SmarTrend identified an Uptrend for Regeneron Pharm (NASDAQ:REGN) on May 2nd, 2017 at $397.84. In approximately 3 months, Regeneron Pharm has returned 25.20% as of today's recent price of $498.11.
In the past 52 weeks, shares of Regeneron Pharm have traded between a low of $325.35 and a high of $543.55 and are now at $498.11, which is 53% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.7% while the 50-day MA has declined 0.4%.
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron Pharmaceuticals serves the healthcare sector in the United States.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Regeneron Pharm shares.